ATA's official monthly journal, is peer-reviewed for topics ranging from the molecular biology of the thyroid gland to clinical management of thyroid disorders.
What happens to thyroid hormone metabolism in end-stage liver disease? New tissue-level data from MASH cirrhosis patients in a @thyroidjournal study reveal distinct changes in T3, T4 and reverse T3 across the liver, portal circulation,and systemic blood
https://t.co/iK5Wtoax41
Can we safely delay thyroidectomy in young children with MEN2? This multicenter cohort explores surgical timing, oncologic outcomes, and the risk of permanent hypoparathyroidism in children undergoing prophylactic-intent surgery.
https://t.co/QTJr3F23qi
#ThyroidJournal
Is there a thyroid ultrasound feature not currently included in risk stratification systems? A multi-institutional report discovers a novel pattern of peripheral punctate echogenic foci and examines its association with papillary thyroid carcinoma.
https://t.co/YrrEwNDK4u
What options remain when advanced thyroid cancer progresses despite multiple prior therapies? Investigators from @MSKCancerCenter evaluated the activity of pemetrexed-based treatment in RAI-refractory differentiated and anaplastic thyroid cancer.
https://t.co/yLbGUTMD7O
Can we better predict outcomes for thyroid cancer patients with brain metastases? A new @thyroidjournal international multicenter study developed a disease-specific prognostic score and identified key factors linked to survival.
https://t.co/5c1YCjDZHT
#ThyroidJournal
When does thyroid RFA become economically comparable to surgery? This one-year micro-costing analysis from @UofT examined the drivers of cost for RFA and hemithyroidectomy and identified key thresholds that could shift the balance.
https://t.co/jWKG65HNtv
#ThyroidJournal
Do patients with Graves' disease and low baseline TRAb really need 12–18 months of antithyroid drugs? In this new @thyroidjournal study, ATD courses <12 months had similar relapse rates, raising the possibility of TRAb-guided shorter treatment.
https://t.co/AkGwofMmZI
Who develops goiter in the U.S.? A new multi-institutional study estimates 1.3–2.5% of working-age adults have goiter, with rates varying by age, sex, and region—raising questions about environmental and geographic influences.
https://t.co/FCxWvoNw0u
#ThyroidJournal#medtwitter
Has the treatment of pediatric hyperthyroidism changed over time? A new @thyroidjournal study from @TelAvivUni found a shift toward longer medical therapy and fewer definitive treatments—but with higher relapse rates, highlighting important tradeoffs.
https://t.co/jbcPygm31C
Does levothyroxine dose affect how often treatment falls out of range? A real-world study by @mettleson and team found patients taking higher doses were more likely to have abnormal TSH levels, suggesting they may benefit from closer follow-up.
https://t.co/FpQH624oDN
What role do thyroid hormones play outside the thyroid? check out this new @thyroidjournal study from Italy that suggests they may influence polycystic kidney disease progression and represent a potential therapeutic target.
https://t.co/V65kJexSeT
#ThyroidJournal
Could a once-weekly subcutaneous levothyroxine injection replace daily pills? A Phase 2 study by @Bianco_Lab and @XerisPharma found it was well tolerated, achieved thyroid hormone targets, and was preferred by many participants.
https://t.co/lpqCoMDwjz
#ThyroidJournal
Should thyroid function be optimized before major cardiac surgery? A new @thyroidjournal study suggests patients with hypothyroidism face higher risks of postoperative complications and long-term cardiovascular events after CABG.
https://t.co/ubDxRYZXtO
#ThyroidJournal
Could "borderline" thyroglobulin antibodies still matter after thyroid cancer treatment? A new @thyroidjournal study suggests detectable TgAb—even below the traditional positive cutoff—may identify patients at higher risk of recurrence.
https://t.co/dwWU2YE2TY
#ThyroidJournal
Should long-term TSH suppression be indefinite in postmenopausal women with DTC? A new study highlights potential effects on bone/muscle/CVS/QOL, especially in low-risk/disease-free women, reinforcing the importance of avoiding unnecessary suppression.
https://t.co/mWT9uF82XV
Can clinical decision tools improve care for patients with indeterminate thyroid nodules? A new @thyroidjournal review examines the current evidence, their strengths and limitations, and why clinical judgment remains essential.
https://t.co/Hnx2wjFxVy
@AmThyroidAssn
Could an elevated TSH be misleading? A new @thyroidjournal study from Japan examines the prevalence and clinical features of macro-TSH, an uncommon cause of apparent subclinical hypothyroidism that can complicate diagnosis and management.
https://t.co/CV6SkAChvs
@AmThyroidAssn
Can low-risk thyroid cancer survivors be safely followed in primary care? Check out this new @thyroidjournal prospective study to see who could potentially be followed with less intensive surveillance.
https://t.co/4gwTXiSHU7
@AmThyroidAssn#ThyroidJournal